Natriumklorid-Glucos, Viaflo Baxter (Sodium Chloride, Glucose)

Sodium chloride supplies sodium and chloride ions that expand extracellular fluid volume and maintain osmotic equilibrium, while glucose delivers immediate calories for cellular metabolism. Together they correct fluid deficits, rebalance electrolytes, and support energy needs during intravenous therapy.

The prescribed dose is determined by the treating physician based on the patient’s clinical condition, fluid losses, electrolyte status, and nutritional requirements. Dosage is individualized and administered under medical supervision.

Safety data for this product in pregnancy and lactation are limited. The prescriber should weigh potential benefits against risks and consider alternative therapies if appropriate. Consultation with a specialist is recommended.

Submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and necessary import documentation.

Compared with plain saline, this formulation adds glucose, offering both electrolyte replacement and an immediate energy source. It is useful when patients need fluid resuscitation plus caloric support, whereas standard saline provides only electrolytes without glucose.

Store the injection solution at 2‑8 °C, keep it refrigerated, protect from light, and avoid freezing or shaking. Use aseptic technique during preparation and ensure the container remains sealed until use.

The solution is given intravenously, typically via a peripheral or central line, under the supervision of qualified healthcare personnel. Infusion rate and volume are adjusted according to the patient’s fluid and electrolyte needs.

Serious risks include severe hypernatremia, anaphylactic reactions, pulmonary edema from fluid overload, and significant electrolyte disturbances that can lead to cardiac arrhythmias. Continuous monitoring during administration helps mitigate these risks.

Patients with known hypersensitivity to sodium chloride, glucose, or any component of the formulation should avoid this product. Caution is also advised for individuals with uncontrolled heart failure, severe renal impairment, or uncontrolled diabetes, where fluid or electrolyte shifts may be hazardous.